OR7-6: Safety and efficacy of ARX201: six month dose-ranging study of a novel long-acting pegylated growth hormone in young adults with growth hormone deficiency
Titel:
OR7-6: Safety and efficacy of ARX201: six month dose-ranging study of a novel long-acting pegylated growth hormone in young adults with growth hormone deficiency
Auteur:
Racz, K. Coculescu, M. Olyinik, V. Popa, M. Popovic, V. Radiuk, K. Senatorova, A.S. Vlasenko, M.V. Norman, T. Juhasz, M. Hoffman, A.R. Axelrod, D.W.